- Home
- NRDY vs IPHA Comparison
NRDY vs IPHA Comparison
Compare NRDY & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDY
- IPHA
- Stock Information
- Founded
- NRDY 2007
- IPHA 1999
- Country
- NRDY United States
- IPHA France
- Employees
- NRDY N/A
- IPHA N/A
- Industry
- NRDY Computer Software: Prepackaged Software
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- NRDY Technology
- IPHA Health Care
- Exchange
- NRDY Nasdaq
- IPHA Nasdaq
- Market Cap
- NRDY 155.4M
- IPHA 167.7M
- IPO Year
- NRDY N/A
- IPHA 2019
- Fundamental
- Price
- NRDY $1.26
- IPHA $1.89
- Analyst Decision
- NRDY Hold
- IPHA Strong Buy
- Analyst Count
- NRDY 3
- IPHA 3
- Target Price
- NRDY $1.25
- IPHA $5.00
- AVG Volume (30 Days)
- NRDY 807.2K
- IPHA 567.8K
- Earning Date
- NRDY 11-06-2025
- IPHA 09-17-2025
- Dividend Yield
- NRDY N/A
- IPHA N/A
- EPS Growth
- NRDY N/A
- IPHA N/A
- EPS
- NRDY N/A
- IPHA N/A
- Revenue
- NRDY $177,867,000.00
- IPHA $14,839,695.00
- Revenue This Year
- NRDY $3.34
- IPHA $22.29
- Revenue Next Year
- NRDY $10.69
- IPHA $43.84
- P/E Ratio
- NRDY N/A
- IPHA N/A
- Revenue Growth
- NRDY N/A
- IPHA N/A
- 52 Week Low
- NRDY $0.77
- IPHA $1.41
- 52 Week High
- NRDY $2.18
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- NRDY 71.16
- IPHA 47.88
- Support Level
- NRDY $0.80
- IPHA $1.80
- Resistance Level
- NRDY $0.88
- IPHA $1.91
- Average True Range (ATR)
- NRDY 0.09
- IPHA 0.13
- MACD
- NRDY 0.05
- IPHA 0.00
- Stochastic Oscillator
- NRDY 96.97
- IPHA 21.58
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.